Search Tag: O-RADS

2025 22 Sep

  Accurate characterisation of ovarian masses remains central to timely treatment decisions and the avoidance of unnecessary surgery. Conventional MRI offers strong soft-tissue contrast yet overlapping appearances between benign and malignant lesions can blur interpretation, particularly for morphologically complex masses. A multi-centre invest1Read more

2025 22 Sep

  Accurate characterisation of ovarian masses remains central to timely treatment decisions and the avoidance of unnecessary surgery. Conventional MRI offers strong soft-tissue contrast yet overlapping appearances between benign and malignant lesions can blur interpretation, particularly for morphologically complex masses. A multi-centre invest1Read more

2025 22 Sep

  Accurate characterisation of ovarian masses remains central to timely treatment decisions and the avoidance of unnecessary surgery. Conventional MRI offers strong soft-tissue contrast yet overlapping appearances between benign and malignant lesions can blur interpretation, particularly for morphologically complex masses. A multi-centre invest1Read more

2025 22 Sep

  Accurate characterisation of ovarian masses remains central to timely treatment decisions and the avoidance of unnecessary surgery. Conventional MRI offers strong soft-tissue contrast yet overlapping appearances between benign and malignant lesions can blur interpretation, particularly for morphologically complex masses. A multi-centre invest1Read more

2025 04 Feb

  Ovarian clear cell carcinoma (CCC) is a distinct subtype of epithelial ovarian cancer with a relatively poor prognosis due to its limited response to platinum-based chemotherapy. Unlike high-grade serous carcinoma, which responds well to chemotherapy, CCC exhibits resistance, making early and accurate identification crucial for effective clin1Read more